$1M Trimmed From $4.8M Award Over Remicade Ads

Law360, New York (March 9, 2010, 2:18 PM EST) -- A Texas appeals court has stripped $1 million from a $4.8 million award to a couple who claimed Johnson & Johnson Inc. subsidiary Centocor Inc.'s advertising misled them into thinking its Remicade drug was safe.

The Texas Court of Appeals for the Thirteenth District sustained the drug company's challenge to a $1 million award of future damages Thursday, saying plaintiffs Patricia and Thomas Hamilton failed to prove such damages at trial.

But the ruling affirmed the central conclusion of a Nueces County jury, which found Centocor...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.